- ALXN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $246.3 million.
- ALXN traded 187,555 shares today in the pre-market hours as of 8:48 AM.
- ALXN is down 4.9% today from yesterday's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ALXN with the Ticky from Trade-Ideas. See the FREE profile for ALXN NOW at Trade-Ideas More details on ALXN: Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. ALXN has a PE ratio of 59.1. Currently there are 15 analysts that rate Alexion Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Alexion Pharmaceuticals has been 1.3 million shares per day over the past 30 days. Alexion has a market cap of $34.4 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.18 and a short float of 2.6% with 2.15 days to cover. Shares are down 6.8% year-to-date as of the close of trading on Monday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.